- Incontinenza Fecale
- Incontinenza Urinaria
- Ricostruzione Mammaria
- Sling per incontinenza
Veritas in Immediate Implant-based Breast Reconstruction Is Associated with Higher Complications Compared with TiLOOP BRA2020 - Gaik Si Quah, James R. French, Annelise Cocco, Jeremy Hsu, Farid Meybodi, Elisabeth Elder
Background: Biologic and synthetic meshes are used in immediate implant-based breast reconstruction for coverage of the lower pole of the implant. This study aimed to compare outcomes of Veritas with TiLOOP bra
Comparison of the Veritas group with the TiLOOP® Bra Group:
- Overall higher complication rate in the Veritas group: 54% vs. 14% of breasts
- Higher seroma rate/ non-integration in the Veritas group: 51.4% vs. 1.6% of breasts
- More implant rotations in the Veritas group: 16.2% vs. 1.1% of breasts
- Higher infection rate in the Veritas group: 18.9% vs. 2.1% of breasts
- More wound dehiscence in the Veritas group: 10.8% vs. 0.5% of breasts
Laparoscopic Lateral Suspension: Benefits of a Cross-shaped Mesh to Treat Difficult Vaginal Vault Prolapse2020 - Jean Dubuisson, Nikolaus Veit-Rubin, Jean Bouquet de Joliniere, and Jean-Bernard Dubuisson
Laparoscopic Lateral Suspension: Benefits of a Cross-shaped Mesh to Treat Difficult Vaginal Vault Prolapse
Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.jmig.2016.01.028
Laparoscopic lateral suspension with mesh for apical and anterior pelvic organ prolapse: A prospective double center study2020 - Liliana Mereu, Saverio Tateo, Maurizio Nicola D’Alterio, Eleonora Russo, Andrea Giannini, Paolo Mannella, Riccardo Pertile, Tommaso Cai, Tommaso Simoncini
The present study analyzed long-term outcomes and complications of laparoscopic lateral suspension (LLS) with mesh to treat apical and anterior pelvic organ prolapse
A prospective cohort study on 125 patients with vaginal bulge and apical +/ anterior prolapse scheduled for LLS who consecutively underwent LLS between April 2013 and January 2017 in Gynecologic Department of Santa Chiara Hospital in Trento and University of Pisa.
Results: 120 patients were included in the study. At 2 years 89 % of patients were asymptomatic and anatomic success rate was 94.2 % for the anterior compartment, 94.9 % for the apical compartment
Medium-term outcomes after robotic-assisted lateral suspension with mesh for advanced multi-compartmental prolapse2019 - Eleonora Russo, Andrea Giannini, Magdalena Montt Guevara, Paolo Mannella, Giulia Misasi, Maria Falcone, Tommaso Simoncini
Medium-term outcomes after robotic-assisted lateral suspension with mesh for advanced multi-compartmental prolapse
This study completed a prospective case series of 115 RALS to treat apical and anterior prolapse stage III or IV, with no or minimal (stage I) posterior defect. Mean follow-up was 28 ± 4 months. Primary outcomes were objective and subjective cure; secondary outcomes were reoperation rate for recurrence, erosion rate and complications.
Results There was a significant improvement in POP-Q score in all treated compartments with an objective cure rate of 88.7% for the anterior and 93.1% for the apical compartment (p < 0.0001)
Self-retaining support implant: an anchorless system for the treatment of pelvic organ prolapse-2-year follow-up2019 - Levy, Padoa, Fekete, Bartfai, Pajor, Cervigni
Self-retaining support implant: an anchorless system for the treatment of pelvic organ prolapse-2-year follow-up
Introduction and hypothesis The search for an improved vag- inal mesh prompted the development of a new anchorless implant. The objective was to report on outcome after 2 years of a technique using a self-retaining support (SRS) implant.
Int Urogynecol J
Mesh versus acellular dermal matrix in immediate implantbased breast reconstructione A prospective randomized trial2016 - D. Gschwantler-Kaulich, P. Schrenk, V. Bjelic-Radisic, K. Unterrieder, C. Leser, A. Fink-Retter, M. Salama, C. Singer
Mesh versus acellular dermal matrix in immediate implantbased breast reconstructione A prospective randomized trial
This prospective, randomized, controlled, multicenter pilot study was performed at four Austrian breast cancer centers. Fifty patients with oncologic or prophylactic indication for mastectomy and IBBR were randomized to immediate IBBR with either an ADM(Protexa) or a titanized mesh (TiLOOPBra).
Da evidenziare sia il 30% di perdita di impianto nel gruppo di Protexa(contro il 7 % di tiloop),sia il miglior outcome estetico e grado di soddisfazione del gruppo Tiloop BRA.